Proionic

18.04.2024 • News

Arkema Acquires Majority Stake in Proionic for Next-Gen Batteries

Arkema is set to acquire a 78% stake in Proionic, a start-up specializing in ionic liquids production. These components are crucial for future lithium-ion batteries. This acquisition expands Arkema’s solutions and strengthens its position in the materials sector across various battery technologies.

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Arkema